Article
Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.
JAMA - 24 May 2006
Plevritis Sylvia K, Kurian Allison W, Sigal Bronislava M, Daniel Bruce L, Ikeda Debra M, Stockdale Frank E, Garber Alan M
Abstract excerpt
CONTEXT: Women with inherited BRCA1/2 mutations are at high risk for breast cancer, which mammography often misses. Screening with contrast-enhanced breast magnetic resonance imaging (MRI) detects cancer earlier but increases costs and results in more false-positive scans. OBJECTIVE: To evaluate the cost-effectiveness of screening BRCA1/2 mutation carriers with mammography plus breast MRI compared with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.